Cidara Therapeutics, Inc.
CDTXDelisted Jan 7, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001610618
Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.
13F holders, Q1 2025
Institutional positions in Cidara Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +6 vs. Q4 2024
- Shares held
- 9.56M
- +2.69M (+39.1%) vs. Q4 2024
- Total value
- $205.9M
- +$22.3M (+12.1%) vs. Q4 2024
- New holders
- 8
- 19 more added
- Sold out
- 2
- 9 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CDTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 255 | $7.36B |
| Q3 2025 | 173 | $3.11B |
| Q2 2025 | 109 | $1.26B |
| Q1 2025 | 46 | $205.9M |
| Q4 2024 | 40 | $183.6M |
| Q3 2024 | 27 | $35.6M |
| Q2 2024 | 26 | $16.9M |
| Q1 2024 | 50 | $20.3M |
| Q4 2023 | 51 | $18.4M |
| Q3 2023 | 52 | $22.7M |
| Q2 2023 | 52 | $29.7M |
| Q1 2023 | 54 | $34.4M |
| Q4 2022 | 42 | $20.2M |
| Q3 2022 | 42 | $17.1M |
| Q2 2022 | 46 | $13.3M |
| Q1 2022 | 44 | $25.2M |
| Q4 2021 | 53 | $39.5M |
| Q3 2021 | 50 | $42.1M |
| Q2 2021 | 55 | $40.5M |
| Q1 2021 | 62 | $56.6M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Cidara Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 1,092,796 | $23.5M | 0.39% | 00.0% | Unchanged |
| VR Adviser, LLC | 1,051,518 | $22.6M | 1.93% | +285,795+37.3% | Added |
| TCG Crossover Management, LLC | 1,005,901 | $21.7M | 2.96% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 990,000 | $21.3M | 0.04% | +620,046+167.6% | Added |
| BVF Inc | 924,642 | $19.9M | 0.81% | −168,154−15.4% | Reduced |
| Bain Capital Life Sciences Investors, LLC | 703,080 | $15.1M | 2.24% | 00.0% | Unchanged |
| Vivo Capital, LLC | 684,276 | $14.7M | 1.95% | +13,676+2.0% | Added |
| Vanguard Group Inc | 509,576 | $11.0M | 0.00% | +292,072+134.3% | Added |
| Vestal Point Capital, LP | 504,542 | $10.9M | 0.78% | +504,542 | New |
| Susquehanna International Group, LLP | 342,476 | $7.38M | 0.01% | +299,853+703.5% | Added |
| Citadel Advisors LLC | 287,775 | $6.20M | 0.01% | +287,775 | New |
| Ikarian Capital, LLC | 248,940 | $5.36M | 1.75% | +195,000+361.5% | Added |
| Acuta Capital Partners, LLC | 125,708 | $2.71M | 3.14% | +71,235+130.8% | Added |
| Standard Life Aberdeen plc | 120,879 | $2.60M | 0.01% | +120,879 | New |
| Point72 Asset Management, L.P. | 113,855 | $2.45M | 0.01% | +107,707+1,751.9% | Added |
| Checkpoint Capital L.P. | 104,380 | $2.25M | 1.23% | −92,569−47.0% | Reduced |
| Renaissance Technologies LLC | 92,517 | $1.99M | 0.00% | −3,100−3.2% | Reduced |
| Boothbay Fund Management, LLC | 79,081 | $1.70M | 0.06% | +63,480+406.9% | Added |
| UBS Group AG | 66,813 | $1.44M | 0.00% | +19,942+42.5% | Added |
| Millennium Management LLC | 63,580 | $1.37M | 0.00% | +27,620+76.8% | Added |
| 5AM Venture Management, LLC | 56,725 | $1.22M | 0.46% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 54,983 | $1.18M | 0.00% | +1,915+3.6% | Added |
| BlackRock, Inc. | 52,896 | $1.14M | 0.00% | −2,629−4.7% | Reduced |
| Goldman Sachs Group Inc | 42,143 | $907.8K | 0.00% | +28,273+203.8% | Added |
| Northern Trust Corp | 33,560 | $722.9K | 0.00% | −397−1.2% | Reduced |
| Jane Street Group, LLC | 27,849 | $599.9K | 0.00% | +15,135+119.0% | Added |
| Bank of America Corp | 27,501 | $592.4K | 0.00% | +27,451+54,902.0% | Added |
| State Street Corp | 22,576 | $486.3K | 0.00% | +3,500+18.3% | Added |
| Schonfeld Strategic Advisors LLC | 21,124 | $455.0K | 0.00% | −28,433−57.4% | Reduced |
| ADAR1 Capital Management, LLC | 20,938 | $451.0K | 0.09% | −4,000−16.0% | Reduced |
| Omers Administration Corp | 19,300 | $415.7K | 0.00% | +6,700+53.2% | Added |
| Sphera Funds Management Ltd. | 17,128 | $368.9K | 0.09% | +17,128 | New |
| Alethea Capital Management, LLC | 14,311 | $308.3K | 0.23% | 00.0% | Unchanged |
| West Michigan Advisors, LLC | 13,500 | $290.8K | 0.10% | +13,500 | New |
| American Century Companies Inc | 10,409 | $224.2K | 0.00% | +10,409 | New |
| Morgan Stanley | 8,217 | $177.0K | 0.00% | +5,787+238.1% | Added |
| Point72 Asia (Singapore) Pte. Ltd. | 1,552 | $33.4K | 0.01% | −533−25.6% | Reduced |
| Tower Research Capital LLC (TRC) | 933 | $20.1K | 0.00% | +933 | New |
| Citigroup Inc | 577 | $12.4K | 0.00% | −7,007−92.4% | Reduced |
| Point72 (DIFC) Ltd | 469 | $10.1K | 0.00% | +271+136.9% | Added |
| Avion Wealth | 250 | $6.00K | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 40 | $860 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 28 | $603 | 0.00% | +28 | New |
| SBI Securities Co., Ltd. | 20 | $431 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 17 | $366 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 6 | $129 | 0.00% | 00.0% | Unchanged |
| StemPoint Capital LP | 0 | $0 | 0.00% | −47,642−100.0% | Sold out |
| Manchester Capital Management LLC | 0 | $0 | 0.00% | −470−100.0% | Sold out |